Apogee CEO sells 80,000 shares at $132.54
Apogee Therapeutics, Inc. director and Chief Executive Officer Michael Thomas Henderson reported an open-market sale of 80,000 shares of Common Stock at a weighted average price of $132.54 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Apogee Therapeutics, Inc. director and Chief Executive Officer Michael Thomas Henderson reported an open-market sale of 80,000 shares of Common Stock at a weighted average price of $132.54 per share. Following the transaction, he directly holds 1,015,987 shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 13, 2025.
Insider Trade Summary 10b5-1
Net Seller: 80,000 shares
Net Sell
1 txn
Insider
HENDERSON MICHAEL THOMAS
Role
Chief Executive Officer
Sold
80,000 shs ($10.60M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 80,000 | $132.54 | $10.60M |
Holdings After Transaction:
Common Stock — 1,015,987 shares (Direct)
Footnotes (2)
- F1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025.
- F2. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $132.50 to $132.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Key Figures
Shares sold: 80,000 shares
Weighted average price: $132.54 per share
Post-transaction holdings: 1,015,987 shares
+1 more
4 metrics
Shares sold
80,000 shares
Open-market sale of Common Stock
Weighted average price
$132.54 per share
Reported sale price for the transaction
Post-transaction holdings
1,015,987 shares
Shares directly held after the sale
Price range of trades
$132.50–$132.68 per share
Range of individual transaction prices
Key Terms
Rule 10b5-1 trading plan, weighted average price, open-market sale, Common Stock
4 terms
Rule 10b5-1 trading plan regulatory
"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported above is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Common Stock financial
"security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Apogee Therapeutics (APGE) report?
Apogee Therapeutics reported that CEO and director Michael Thomas Henderson sold 80,000 shares of Common Stock in an open-market transaction. The weighted average sale price was $132.54 per share, based on multiple trades within a disclosed price range.
Was the Apogee Therapeutics (APGE) insider sale made under a Rule 10b5-1 plan?
Yes. The filing states the transaction was executed under a Rule 10b5-1 trading plan adopted on August 13, 2025. Such plans pre-schedule trades, indicating the timing of this sale was determined in advance rather than being discretionary.
What does a weighted average sale price mean in the APGE Form 4 filing?
The weighted average price of $132.54 reflects multiple trades at prices from $132.50 to $132.68. The insider combined these trades into one reported figure, and offers to provide exact share counts and prices for each individual trade within the range upon request.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates